CanChip | Pancreas-on-Chip / PDAC Studies

Partner-enabled pancreas-on-chip studies for PDAC research.

Available through NAMina Bio with CanChip for human-relevant drug-response and translational studies. The pancreas/PDAC model is one defined application within CanChip's broader customizable tumor-on-chip capability; model configuration and study design can be adapted to the scientific objective, subject to technical feasibility.

NAMina Bio integration

NAMina Bio can connect the tumor-on-chip study with complementary 3D models, molecular profiling and downstream interpretation to support a program-level decision. Scope and pricing are project-specific; use Get a quote.